Oscar Health reported a significant swing to profit in Q3 2026, driven by strong underwriting and membership growth. This positive performance led the company to raise its full-year 2026 operating earnings and revenue guidance, indicating a strong financial trajectory and likely positive market reaction.
Oscar Health announced robust third-quarter 2026 financial results, reporting a swing to profit with $0.49 EPS and $5.14 billion in revenue. This positive performance was attributed to strong underwriting and membership growth, signaling improved operational efficiency and market penetration. The company subsequently raised its full-year 2026 operating earnings guidance to $850 million-$950 million and projected total revenue between $19 billion and $19.3 billion. This news is highly significant for investors as it indicates a strong turnaround and positive future outlook for Oscar Health, likely leading to a substantial positive short-term impact on its stock price. Long-term implications suggest sustained growth and profitability, reducing previous concerns about the company's path to profitability. The key opportunity for traders is to capitalize on the expected upward movement in OSCR shares following this strong earnings report and guidance increase.